How the Non-Small Cell Lung Cancer (NSCLC) Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theNon-Small Cell Lung Cancer (NSCLC) Market from 2025 to 2034?
The non-small cell lung cancer (NSCLC) market is anticipated to grow due to the rising prevalence of tobacco use. In an average person, use of tobacco usually entails smoking, chewing, or snuffing tobacco products, all of which introduce harmful substances like nicotine into the body. Lung cells exposed to tobacco smoke, which carries numerous carcinogens, can sustain DNA damage that cause mutations and unregulated growth of cancerous cells, a characteristic of NSCLC. The 2024 National Youth Tobacco Survey, published by the US Food and Drug Administration (USFDA) in October 2024, revealed that about 2.25 million (1.1%) students were active tobacco users, including 1.58 million (10.1%) high school students and around 640,000 (5.4%) middle school students. Also, about 760,000 (2.8%) students reported current use of combustible products; an estimated 840,000 (3.0%) admitted to using multiple tobacco products. Given these statistics, the growth of the non-small cell lung cancer (NSCLC) market is likely being fueled by the escalating tobacco use. Moving to the next factor, escalating levels of air pollution are poised to boost the non-small cell lung cancer (NSCLC) market. Toxic substance releases into the earth’s atmosphere, whether in forms such as gases or particles, result in air pollution that negatively impacts human health. Elevated risk of NSCLC can be linked to exposure to air pollution, which can trigger inflammation, damage DNA and cause lung cell mutations, culminating in cancerous growths. Data from the Switzerland-based World Health Organization in June 2023 suggested that 7 million premature deaths annually were associated with ambient and household air pollution. Furthermore, around 2.4 billion people are exposed to perilous levels of domestic air pollution due to the use of unclean combustion materials like coal, kerosene, and biomass for cooking. In September 2022, the World Bank, an American financial establishment, stated that health damages attributed to air pollution would reach about $8.1 trillion annually, equivalent to 6.1% of worldwide GDP. Given these statistics, the steady surge of air pollution makes it another significant factor propelling the growth of the non-small cell lung cancer (NSCLC) market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13232&type=smp
#How Does the ProjectedNon-Small Cell Lung Cancer (NSCLC) Market Growth Compare Over the Forecast Period?
The market for non-small cell lung cancer (NSCLC) has witnessed a significant expansion lately. It is projected to escalate from $20.1 billion in 2024 to $22.35 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. Factors contributing to the growth of this market during the previous period are the advancements in immunotherapy, genomic profiling, precision medicine, enlargement of clinical trials and smoking cessation initiatives.
In the coming years, there’s expected to escalate growth in the non-small cell lung cancer (NSCLC) market. This market is projected to hike up to $33.29 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 10.5%. The development during the forecast timeline can be credited to the introduction of combination therapies, the application of artificial intelligence (AI), the broadening of personalized vaccines, international research partnerships, and patient-focused care. In the prediction period, predominant trends will encompass the inclusion of telemedicine in oncology, liquid biopsy technologies, advancements in diagnostic technologies, adoption of minimally invasive surgical methods, and immune checkpoint inhibitors.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13232
How Are Market Trends and Innovations Revolutionizing theNon-Small Cell Lung Cancer (NSCLC) Industry in Recent Times?
Leading firms in the non-small cell lung cancer (NSCLC) market are concentrating on developing diverse treatment options such as monotherapy treatments to gain a competitive advantage. Monotherapy treatment implies employing a single drug or therapy for treating a medical condition or disorder instead of using a mix of various approaches. For example, in June 2022, Swiss pharmaceutical firm Novartis AG received a green light from the European Commission (EC), a governance body based in Belgium, for its product Tabrecta (capmatinib) aimed at treating adult patients diagnosed with advanced non-small cell lung cancer with METex14 skipping. This provides a cutting-edge targeted therapeutic option for European patients who have undergone previous treatment and have advanced non-small cell lung cancer (NSCLC) with mutations leading to MET exon 14 (METex14) skipping. This is currently the most favored targeted treatment for advanced NSCLC that comes with changes leading to METex14 skipping.
Which Key Market Players Are Shaping the Future and Growth of theNon-Small Cell Lung Cancer (NSCLC) Market?
Major companies operating in the non-small cell lung cancer (NSCLC) market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Clovis Oncology, Revolution Medicines
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Non-Small Cell Lung Cancer (NSCLC) Market, and How Do They Contribute to Growth?
The non-small cell lung cancer (NSCLC) market covered in this report is segmented –
1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types
2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Squamous Cell Carcinoma
2) By Large Cell Carcinoma: Undifferentiated Large Cell Carcinoma, Large Cell Neuroendocrine Carcinoma
3) By Adenocarcinoma: Invasive Adenocarcinoma, Bronchioloalveolar Carcinoma
4) By Other Types: Mixed Cell Type Carcinoma, Sarcomatoid Carcinoma
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13232&type=smp
What Regions Are Dominating the Non-Small Cell Lung Cancer (NSCLC) Market Growth?
North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (NSCLC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Non-Small Cell Lung Cancer (NSCLC) Market 2025, By The Business Research Company:
Urinary Tract Cancer Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
Small Cell Lung Cancer Therapeutics Global Market Report 2024
Bridges, Gateways And Routers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bridges-gateways-and-routers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
